Shares in genetic testing firm 23andMe dropped Monday after the company declared bankruptcy and California reminded consumers ...
After nearly two decades in business, San Francisco-based 23andMe filed for Chapter 11 bankruptcy protection on Sunday and ...
Pharmaceutical companies and precision medicine companies could also use the data to develop new drugs. It wouldn’t be the ...
Following the firm’s bankruptcy, researchers hope that they will be able to continue accessing the valuable data set even if ...
HighTower Advisors LLC raised its stake in shares of HubSpot, Inc. (NYSE:HUBS – Free Report) by 65.6% during the 4th quarter, ...
The third among the 10 stocks insiders are getting rid of in March is a commercial-stage biotech, Adaptive Biotechnologies ...
The full sample set included 4,292 companies ... the first day of trading after the company disclosed it would sell up to 38 million additional shares.
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
Genetic testing company 23andMe announced it has filed for Chapter 11 bankruptcy. Here's what it means for users' genetic data.
We recently published a list of the 12 Best Up and Coming Stocks to Buy According to Wall Street Analysts. In this article, ...
which currently states that the company won’t sell customers’ identifiable genetic data, and that they’ll only share data with researchers if customers opt in. The privacy policy states that ...